Elekta
60.75
SEK
+0.5 %
EKTA B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Less than 1K followers
+0.5%
-0.65%
-4.1%
-14.68%
-10.53%
-24.7%
-41.02%
-44.62%
+596.4%
Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.
Read moreMarket cap
23.3B SEK
Turnover
11.33M SEK
Revenue
18.12B
EBIT %
11.25 %
P/E
17.82
Dividend yield-%
3.95 %
Financial calendar
21/2
2025
Interim report Q3'25
28/5
2025
Annual report '25
4/9
2025
General meeting '25
ShowingAll content types
Cancercentrum i Tyskland behandlar den första patienten i världen med den nya CT-linjäracceleratorn, Elekta Evo
German cancer center treats first patient in the world with Elekta Evo CT-Linac
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools